Total audited revenue for 2024 was $19.5 million. The first two months of 2025,our unaudited revenue is about $5.7million,more than 50% growth year over year for the first two months of 2024,and exce
SHANGHAI,March 17,2025-- Singapore Treasure Carbon TechPte. Ltd. (SGTC) and CHCC Capital (Singapore) Pte. Ltd. have jointly launched a fund that will invest in international carbon credit assets compl
SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors
HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to
